-
Using ‘neurodivergent’ as a catch‑all term is problematic—here’s why
Medical Mythbusting Commentary for September 18, 2026 Source:Using ‘neurodivergent’ as a catch‑all term is problematic—here’s why Reference: Mapping Clinical Diagnoses Associated With Neurodiversity and Neurodivergence in Mental Health Research
-
Too many confounding factors to conclude that there is an association between melatonin use and increased congestive heart failure risk
Medical Mythbusting Commentary for September 8, 2026 Source:Melatonin Use Linked to Massively Increased Risk of Heart Failure Reference:Long-term melatonin use linked to 90% higher heart failure risk
-
Genetic discovery of 36 genes related to the pathophysiology of OCD and tics may lead to teh development of new treatments.
Medical Mythbusting Commentary for September 3, 2026 Source:Genetic discovery may lead to treatments for OCD and tics Reference:Whole-exome sequencing in individuals with obsessive–compulsive disorder and chronic tic disorders identifies 36 large-effect risk genes
-
AI-calculated brain age predicts dementia risk years before doctors can see it
Medical Mythbusting Commentary for August 21, 2026 Source:AI-calculated brain age predicts dementia risk years before doctors can see it Reference:Comparison of Brain Age With Standard MRI Assessment for Dementia Risk Stratification in Subjective and Mild Cognitive Impairment
-
SuperAgers retain exceptional memory through mechanisms beyond genetics
Medical Mythbusting Commentary for July 27, 2026 Source:SuperAgers retain exceptional memory through mechanisms beyond genetics Reference:SuperAging is not the inverse of common-variant Alzheimer’s risk: evidence across genetic ancestries
-
Newer GLP-1 medications may reduce alcohol-related hospitalization risk
Medical Mythbusting Commentary for July 23, 2026 Source:Newer GLP-1 medications may reduce alcohol-related hospitalization risk Reference:Association between GLP-1 receptor agonists and alcohol-related hospitalisations among adults with alcohol use disorder: multi-target trial emulation study.
-
Millions take omega-3 fish oil for brain health but a new study found no benefit at least in the short term.
Medical Mythbusting Commentary for June 30, 2026 Source:Millions take omega-3 fish oil for brain health but a new study found no benefit Reference: CNS target engagement of high-dose DHA supplementation in older adults at risk for dementia: a randomised, double-blind, placebo-controlled trial
-
Weight-loss drug approved to treat sleep apnea in Canada
Medical Mythbusting Commentary for June 26, 2026 Source:Weight-loss drug approved to treat sleep apnea in Canada
-
There is no credible evidence to support this headline: “Why you should be brushing your teeth with your left hand to prevent dementia”
Medical Mythbusting Commentary for June 25, 2026 Source:Why you should be brushing your teeth with your left hand to prevent dementia